Chuo-ku, Japan

Mitsunori Matsuda

USPTO Granted Patents = 6 

Average Co-Inventor Count = 6.0

ph-index = 3

Forward Citations = 54(Granted Patents)


Location History:

  • Osaka, JP (2008)
  • Chuo-ku, JP (2009 - 2016)

Company Filing History:


Years Active: 2008-2016

Loading Chart...
6 patents (USPTO):Explore Patents

Title: Innovations by Mitsunori Matsuda in Immunosuppressants

Introduction

Mitsunori Matsuda, an accomplished inventor based in Chuo-ku, Japan, has made significant contributions to the field of pharmaceuticals with a notable portfolio of six patents. His work primarily focuses on developing compounds that serve crucial medical functions, particularly in the realm of immunosuppression.

Latest Patents

One of his latest patents centers on the "Method of producing FR901228," which discloses depsipeptides and their congeners known for their pharmacological activity. The compounds, including FR901228, have shown effectiveness as immunosuppressants and are designed for the prevention and treatment of inflammatory, autoimmune, and immune system-related diseases. This is particularly relevant for conditions such as graft-versus-host disease and enhancing graft/tissue survival following transplants. The patent also outlines innovative methods for inhibiting lymphocyte activation, proliferation, and suppression of IL-2 secretion.

Career Highlights

Matsuda’s career is marked by his involvement with Astellas Pharma GmbH, where he continues to push the boundaries of pharmaceutical research. His dedication to enhancing patient outcomes through innovative treatment options has positioned him as a key figure in this vital industry.

Collaborations

Working alongside talented colleagues such as Satoshi Ueda and Yoko Watamoto, Matsuda's collaborative efforts have enhanced the development of therapeutic solutions. Their combined expertise has fostered an environment of innovation, driving the creation of new medical therapies that address critical health challenges.

Conclusion

Mitsunori Matsuda exemplifies the essence of innovation within the pharmaceutical field. With his extensive patent portfolio and commitment to addressing complex health issues, his work not only contributes to the scientific community but also significantly impacts patient care worldwide. As he continues to explore new possibilities in drug development, Matsuda remains a vital asset to the ongoing advancement in immunosuppressive therapies.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…